This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
trillion meat market by 2040. We can now move forward with confidence that the cultivation conditions are prime for producing plant-based proteins that can be marketed globally and integrated into our SUS-TAINN Branded RUTF in development.”. Bloomberg also projects that plant-based meat could make up a quarter of the USD $1.8
” The patent provides protection through 2040 and describes use of the Company’s investigational drug ANEB-001 to treat acute cannabinoid overdose. We recently announced a key milestone with the issuance of a method of use patent for ANEB-001, providing protection through 2040. Chief Executive Officer of Anebulo. “We
Legislation passed last July allows a Consultant doctor to prescribe medicinal cannabis, but it is restricted to just three conditions. A symposium in Limerick has heard that the medical cannabis access programme here is too restrictive and needs to be extended to include people who suffer with chronic pain.
Studies estimate that the number of people suffering from rheumatoid arthritis may rise to over 78 million by 2040. The rising prevalence of rheumatoid arthritis, psoriatic arthritis, and inflammatory bowel disease are driving demand for TNF inhibitors like MYMD-1.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content